Last reviewed · How we verify
NCT05768243
Hyaluronic Acid Versus Red Injectable Platelet Rich Fibrin in Treatment of Periodontitis
Phase 4 trial testing Hyaluronic acid in Periodontitis Chronic Generalized Severe in 75 participants. Completed in 17 September 2022.
24 July 2022
Quick facts
| Lead sponsor | Beirut Arab University |
|---|---|
| Phase | Phase 4 |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 75 |
| Start date | 1 March 2021 |
| Primary completion | 24 July 2022 |
| Estimated completion | 17 September 2022 |
| Sites | 1 location across Lebanon |
Drugs / interventions tested
- Hyaluronic acid (HYALURONIC ACID) — full drug profile →
- red injectable platelet rich fibrin (i-prf)
Conditions studied
- Periodontitis Chronic Generalized Severe — all drugs for Periodontitis Chronic Generalized Severe →
Sponsor
Beirut Arab University
Who can join
Adults 20 to 60, any sex, with Periodontitis Chronic Generalized Severe. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
the aim of this clinical trial is to compare the efficacy of hyaluronic acid (HA) used as an adjunctive to scaling and root planing (SRP) and red injectable platelet rich-fibrin (i-PRF) in the non-surgical treatment of stage III periodontitis. The main question it aims to answer is: is there a difference between HA and red i-prf when used as an adjunct to SRP in terms of efficacy? Participants who are eligible will be assigned to one of the treatment groups: * Group 1= receives HA+ SRP * Group 2= receives red i-prf + SRP * Group 3= receives only SRP Researchers will compare Groups 1,2 and 3 to see if there's a difference in the periodontal parameters measured.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05768243
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Hyaluronic acid
Trials testing the same drug.
- NCT07236632 — Hyaluronic Acid vs Botulinum Toxin Injection in Treatment of Lifelong Drug-Resistant Premature Ejaculation: Randomized S · NA · not yet recruiting
- NCT06437054 — Verification of the Efficacy/Safety of the Mixed Drug Injectable Delivery Vehicle for Treating Intractable Hearing Loss · Phase 1, PHASE2 · not yet recruiting
- NCT07437885 — Effects of the Adjunctive Use of Hyaluronic Acid-based Gel With Coranally Advanced Flap in the Gingival Recession · Phase 1, PHASE2 · completed
- NCT06253975 — Randomized, Controlled, Multicenter Study of Extracellular Vesicles From Human Adipose Tissue Promoting Wound Healing · NA · unknown
- NCT06694532 — EffIcacy Between Arthrocentesis With High Versus Low Molecular Weight Hyaluronic Acid in Treatment of TMJ Disorders · Phase 1, PHASE2 · recruiting
Other Beirut Arab University trials
Trials by the same sponsor.
- NCT07086482 — Effect of Cyanoacrylate Tissue Adhesive Versus Collagen Sponge on Palatal Donor Site Healing · EARLY_PHASE1 · recruiting
- NCT07002138 — The Acceptability of Digital Impression Compared to Conventional Technique in Children · NA · completed
- NCT05895708 — Effect of Specific Postural Corrective Exercises on EMG Activity in Patients With Forward Head Posture · NA · unknown
- NCT05756010 — Effect of Forward Head Correction on EMG of Masticatory Muscles in Patients With TMD · NA · unknown
- NCT07023939 — Atraumatic Versus Silver-Modified Atraumatic Restorative Treatment in Primary Molars · Phase 4 · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05768243 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Beirut Arab University
- Last refreshed: 14 March 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05768243.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing